|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nicole DeFeudis has been keeping tabs on how the first round of IRA prices has impacted sales since they went into effect at the start of the year. So far, AbbVie and Amgen have mentioned the hit to sales of drugs like Imbruvica and Enbrel. |
|
|
|
Lydia Ramsey Pflanzer |
Deputy Editor, Endpoints News
|
|
|
|
|
|
|
by Nicole DeFeudis
|
At least two drugmakers say they’re feeling the impact of the Inflation Reduction Act, after the first drug prices negotiated under the law took effect in January... | |
|
|
|
 |
|
A worker operates an automatic filling machine at Lonza's facility in Stein, Switzerland (Credit: Lonza) |
|
|
|
by Anna Brown
|
BASEL, Switzerland— Lonza said it wants to own the commercial market for antibody-drug conjugates, with a new manufacturing site set to come online next... | |
|
|
|
|
|
|
by Max Bayer
|
Eli Lilly is committing to its roots, allocating $4.5 billion for new manufacturing investments across Indiana as drugmakers pledge more US projects. The world’s largest... | |
|
|
|
|
|
|
by Kyle LaHucik
|
BeOne Medicines has greatly expanded its pipeline over the years, bringing 18 new molecular entities to the fore across 2024 and 2025. But that also... | |
|
|
|
 |
|
Mike Doustdar, Novo Nordisk CEO (Nichlas Pollier/Bloomberg via Getty Images) |
|
|
|
by Elizabeth Cairns
|
A million patients with obesity are already taking Novo Nordisk’s Wegovy pill, CEO Mike Doustdar said Wednesday, despite the market entry of Lilly’s Foundayo. Novo's... | |
|
|
|
|
|
|
by Kyle LaHucik
|
GSK is further delving into the cardiometabolic space — and deepening its relationship with China biotechs — in a $1 billion biobucks deal with an... | |
|
|
|
|
|
